Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targe... Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate, roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. Mehr anzeigen
Preliminary unaudited product revenue for the fourth quarter of 2024 is expected to be approximately $63 million, up approximately 366% vs. Q4 2023 and 41% vs. Q3 2024Preliminary unaudited product...
WESTLAKE VILLAGE, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful...
ZORYVE cream 0.05% provided meaningful disease clearance and rapid reduction in itch in pivotal trialsRoflumilast cream was well tolerated and demonstrated a favorable safety and tolerability...
WESTLAKE VILLAGE, Calif., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.615 | -4.43722943723 | 13.86 | 14.36 | 12.61 | 1785488 | 13.32801025 | CS |
| 4 | -1.765 | -11.7588274484 | 15.01 | 16.2 | 12.61 | 1800587 | 14.28007407 | CS |
| 12 | 4.505 | 51.5446224256 | 8.74 | 16.2 | 8.21 | 2134114 | 12.21678785 | CS |
| 26 | 3.355 | 33.9231547017 | 9.89 | 16.2 | 8.01 | 2054669 | 10.79879497 | CS |
| 52 | 9.805 | 285.029069767 | 3.44 | 16.2 | 3.295 | 2919012 | 9.53446436 | CS |
| 156 | -1.755 | -11.7 | 15 | 27.4 | 1.76 | 1868716 | 9.02276011 | CS |
| 260 | -9.805 | -42.5379609544 | 23.05 | 40.88 | 1.76 | 1194344 | 10.15805363 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
